PSCH

Invesco S&P SmallCap Health Care ETF

HealthcareNASDAQ-GMInvesco ETF
$54.36
$-0.39 (-0.72%)
Delayed ≥20 min · Sep 3, 2026

Key Statistics

Net Assets (AUM)
$183.20M
Expense Ratio
See prospectus
Previous Close
$54.75
Day Range
- – -
52-Week Range
$39.08 – $56.45
Volume
5.50K
Avg Vol (50D)
17.23K
Beta
0.84

Historical Performance

1M
+0.30%
3M
+18.70%
6M
+30.99%
YTD
+23.39%
1Y
+31.29%
3Y
+36.33%
5Y
-13.70%

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

Invesco Private Prime Fund 21.33%
Invesco Private Government Fund 7.98%
Krystal Biotech, Inc. 4.24%
Glaukos Corp. 4.12%
PTC Therapeutics, Inc. 3.26%
Protagonist Therapeutics, Inc. 3.22%
Teleflex Inc. 3.21%
Alkermes PLC 2.96%
TransMedics Group, Inc. 2.96%
RadNet, Inc. 2.89%
BrightSpring Health Services, Inc. 2.80%
Merit Medical Systems, Inc. 2.73%
TG Therapeutics, Inc. 2.44%
Indivior Pharmaceuticals, Inc. 2.43%
Ligand Pharmaceuticals Inc. 2.32%
ICU Medical, Inc. 2.21%
ADMA Biologics, Inc. 2.21%
Corcept Therapeutics Inc. 1.99%
Prestige Consumer Healthcare Inc. 1.98%
Supernus Pharmaceuticals, Inc. 1.87%
Acadia Pharmaceuticals Inc. 1.83%
Integer Holdings Corp. 1.81%
Waystar Holding Corp. 1.75%
Veracyte, Inc. 1.72%
Concentra Group Holdings Parent, Inc. 1.70%

Top 25 holdings as of Feb 28, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About PSCH

The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC (the “Index Provider”) compiles, maintains and calculates the Underlying Index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard (“GICS®”). These companies are principally engaged in the business of providing healthcare-related products, facilities, technology, supplies, and equipment and services, including in areas such as biotechnology, pharmaceuticals and life sciences. The Underlying Index selects constituents from the S&P SmallCap 600® Index, which is comprised of common stocks of approximately 600 small-capitalization companies that generally represent the small-cap segment of the U.S. equity market. As of October 31, 2024, the Underlying Index was comprised of 70 constituents with market capitalizations ranging from $424.5 million to $7.3 billion.  The Fund employs a “full replication” methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index.Concentration Policy. The Fund will concentrate its investments (i.e., invest 25% or more of the value of its total assets) in securities of issuers in any one industry or group of industries only to the extent that the Underlying Index reflects a concentration in that industry or group of industries. The Fund will not otherwise concentrate its investments in securities of issuers in any one industry or group of industries. As of August 31, 2024, the Fund had significant exposure to the health care sector. The Fund’s portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.

PSCH News

Data for PSCH is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.